. "0770-3198" . "5"^^ . "Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry"@en . "Clinical Rheumatology" . "[7E83DE89F62E]" . "Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry" . . "RIV/00098892:_____/13:#0000471!RIV14-MZ0-00098892" . "Smr\u017Eov\u00E1, Andrea" . "59210" . . . "8"^^ . "RIV/00098892:_____/13:#0000471" . "The Czech national registry ATTRA collects data from patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and juvenile idiopathic arthritis, treated with the biologic drugs. ATTRA is a prospective centralized computerized registry of patients with a focus on efficacy, safety, and quality of life data. Abatacept is approved as a second-line agent which can be prescribed after a failure of at least one TNF-alfa inhibitor. Data of patients treated with abatacept has been collected since 2008."@en . . "The Czech national registry ATTRA collects data from patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and juvenile idiopathic arthritis, treated with the biologic drugs. ATTRA is a prospective centralized computerized registry of patients with a focus on efficacy, safety, and quality of life data. Abatacept is approved as a second-line agent which can be prescribed after a failure of at least one TNF-alfa inhibitor. Data of patients treated with abatacept has been collected since 2008." . "32" . . . . "10" . "1"^^ . . . . . . "abatacept, registry, rheumatoid arthritis"@en . . "CZ - \u010Cesk\u00E1 republika" . "I, V" . "Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry"@en . "Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry" . . .